Importantly, mutations in other components of Hh signaling pathway, such as Ptch (present in > 50% of SHH medulloblastoma) (Kool et al, 2014), will also affect Sufu protein levels, given the effect of pathway activation on Sufu protein mediated by Fbxl17. This evidence concerns the gene PTCH1 and medulloblastoma.